Pain Management Therapeutics Market: Global Industry Research Report 2020-2028
Envisage report cover

Pain Management Therapeutics Market: COVID-19 Impact and Global Analysis Forecast to 2028

Published Date: May 2021

No. of Pages: 209

Status: Upcoming

Report Code: EMR100094

Global Pain Management Therapeutics Market By rising the population of the world find itself on high chronic pain epidemics, hence the necessity to handle chronic pain as a publically declared health issue by scholars and public health practitioners is witnessing significant strength. Currently, around 20% of the world’s total population suffer from chronic pain. Various factors such as increased number of surgeries, changing lifestyles, rising prevalence of chronic diseases and rising geriatric population continue to add approximately 10% new patients to the aforementioned numbers every consecutive year. Pain management also called as algiatry is a branch ofmedicinal studieswhich utilizes an interdisciplinary approach to facilitate and improve the overall quality of life. Pain is result of tissue damage or trauma and the intensity of pain varies from person to person. Pain can be bifurcated on the basis of itsduration and occurrence and coupled with the affected body part. The very first stage of treatment for pain is termed as pain killer drugs or pharmaceutical therapeutics. Various other pain management procedures include pain managing devices, physiotherapy and chiropractor therapy. Pain is a usually defined as a type of unpleasant physical sensation generally caused by any injury or illness. The pain management field is categorized on a large scale into medicinal and physical treatment. Several cancer therapies arise pain and trauma injuries have fueled the overall demand for efficient pain management services. Increasing focus of pain management service providers on commercialization pain management drugs with minimal side effects, ambulatory pain management solutions and reformed reimbursement policies are some of the key factors shaping the growth prospect of pain management therapeutics marketglobally.

Increased focus on palliative care treatment, reimbursement for pain management treatment, supportive regulations andgrowing healthcare expenditures coupled with increasing prevalence of cancer patients are some of the key factors surging the growth of the overall global pain management therapeutics market. Moreover, strong prevalence of chronic pain ailments, efficient and effective treatment options as well as favorable regulatory framework are some of the major drivers propelling the growth of the global pain management therapeutics market.Also, consistent focus of medical devices manufacturers to come up with cost effective products and increase in the number of trauma cases along with accidental injuries is fuelling the growth of the global pain management therapeutics market. However, limited availability, lack of awareness for advanced pain medication, chronic side effects and higher probabilities of addiction from pain medicines is expected to impede the growth of global pain management therapeutics market.

The global pain management therapeutics market can be segmented on the basis of devices, disease condition, class of drug, end-use industry and geography. On the basis of devices, the global pain management therapeutics market can be segmented into analgesic infusion pumps, spinal cord stimulators, neurostimulation devices, electrical stimulation devices and radiofrequency ablation devices. On the basis of disease condition, the global pain management therapeutics market can be segmented into trauma, injury, cancer, anesthesia, surgical pain, terminal conditions, neuropathic pain and others. On the basis of class of drug, the global pain management therapeutics market can be segmented into narcotics pain killer, non-narcotics analgesics, muscle relaxants, anti-anxiety drugs and others. On the basis of end-use industry, the global pain management therapeutics market can be segmented into surgical centers, clinics and hospitals. In terms of geography, the global pain management therapeutics market can be divided into North America, Latin America, Europe, Asia-Pacific and Middle East & Africa.
The global pain management therapeutics market is predictable to witness a soaring competition in the near future owing to entry of a large number of local and generic manufacturers. Key players pertaining in the global pain management therapeutics market include Endo Health Solutions, Pfizer, Inc., Eli Lilly & Co., AstraZeneca PLC., Purdue Pharma L.P. and Johnson & Johnson among others.

The global pain management therapeutics market can be segmented
On the basis of devices
• Analgesic infusion pumps
• Spinal cord stimulators
• Neurostimulation devices
• Electrical stimulation devices
• Radiofrequency ablation devices

On the basis of disease condition
• Trauma
• Injury
• cancer
• Anesthesia
• Surgical pain
• terminal conditions
• Neuropathic pain
• Others

On the basis of class of drug
• Narcotics pain killer
• Non-narcotics analgesics
• Muscle relaxants
• Anti-anxiety drugs
• Others

On the basis of end-use industry
• surgical centers
• clinics
• hospitals

On the basis of region
• North America
• Latin America
• Europe
• Middle East & Africa
• Asia Pacific

The Leading Key Players in Pain Management Therapeutics Market

Endo Health Solutions
Pfizer Inc.
Eli Lilly & Co.
AstraZeneca PLC.
Purdue Pharma L.P.
Johnson & Johnson